Syndecans and the lymphoid system

Leukemia and Lymphoma

Volumn 38, Issue 3-4, 2000, Pages 271-281

  Kopper, László ^a,b   Sebestyén, Anna ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NONE   (Hungary)

Author keywords

Heparan sulfate; Lymphoma; Syndecan

Indexed keywords

HEPARAN SULFATE; PROTEOGLYCAN; SYNDECAN;

B LYMPHOCYTE DIFFERENTIATION; CELL INTERACTION; CYTOPLASM; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; HUMAN; LYMPHATIC SYSTEM; LYMPHOCYTE PROLIFERATION; MYELOMA; NONHODGKIN LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; REVIEW;

EID: 0034064995     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009087018     Document Type: Review

References (88)

1. Kim, C.W., Goldberger, O.A., Gallo, R.L., Bernfield, M. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Molecular Biology of the Cell, 5, 797-805.
2. Woods, A., Couchman, J.R. (1998) Syndecans: synergestic activators of cell adhesion. Trends in Cell Biology 8, 189-192.
3. Zimmermann, P., David, G. (1999) The syndecans, tuners of transmembrane signaling. FASEB Journal 13, S91-S100.
4. Carey, D.J. (1997) Syndecans: multifunctional cell-surface co-receptors. Biochemical Journal 327, 1-16.
5. Oh, E.S., Couchman, J.R., Woods, A. (1997) Serine phosphorylation of ssyndecan-2 proteoglycan cytoplasmyc domain. Archives of Biochemistry and Biophysics 344, 67-74.
6. Spring, J., Goldberger, O.A., Jenkins, N.A., Gilbert, D.J. Copeland, N.G., Bernfield, M. (1994) Mapping of the syndecan genes in the mouse: linkage with members of the myc gene family. Genomics 21, 597-601.
7. Kaukonen, J., Alanen-Kurki, L., Jalkanen, M., Pulotie, A. (1997) The mapping and visual ordering of the human syndecan-1 and N-myc genes near the telomeric region of chromosome 2p. Human Genetics 99, 295-7.
8. Mali, M., Jaakola, P., Arvilommi, A.M., Jalkanen, M. (1990) Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. Journal of Biological Chemistry 265, 6884-6889.
9. Vihinen, T., Auvinen, P., Alanen-Kurki, L., Jalkanen, M (1993) Structural organization and genomic sequence of mouse syndecan-1 gene. Journal of Biological Chemistry 268, 7261-7269.
10. Oettinger, H.F., Streeter, H., Lose, E., Copeland, N.G., Gilbert, D.J., Justice, M.J., Jenkins, N.A., Mohandas, T., Bernfield, M. (1991) Chromosome mapping of the murine syndecan gene. Genomics 11, 334-338.
11. Vihinen, T., Maata, A., Jaakola, P., Auvinen, P., Jalkanen, M. (1996) Functional characterization of mouse syndecan-1 promoter. Journal of Biological Chemistry 271l: 12532-15541.
12. Hinkes, M.T., Goldberger, O.A, Neumann, P.E., Kokenyesi, R., Bernfield, M. (1993) Organization and promoter activity of the mouse syndecan-1 gene. Journal of Biological Chemistry 268, 11440-11448.
13. Cizmeci-Smith, G., Langen, E., Youkey, J., Showalter, L.J., Carey, D.J. (1997) Arteriosclerosis, Thrombosis, and Vascular Biology 17, 172-180.
14. Elenius, K., Maatta, A., Salmivirta, M., Jalkanen, M. (1992) Growth factors induce 3T3 cells to express bFGF-binding syndecan. Journal of Biological Chemistry 267, 6435-6441.
15. Bernfield, M., Kökényesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L., Lose, E.J. (1992) Biology of the syndecans: a family of four transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology, 8, 365-393.
16. Kökényesi, R., Bernfield, M. (1994) Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. Journal of Biological Chemistry 269, 12304-12309.
17. Habuchi, H., Habuchi, O., Kimata, K. (1998) Biosynthesis of heparan sulfate and heparin. How are the multifunctional glycosaminoglycans built up? Trends in Glycoscience and Glycotechnology 10, 65-80.
18. Lyon, M., Gallagher, J.T. (1998) Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biology 17, 485-493.
19. Kiefer, M.C., Ichihara, M., Swiedler, S.J., Crawford, K., Stephans, J.C., Barr, P.J. (1991) The molecular biology of heparan sulfate fibroblast growth factor receptor. Annuals of the New York Academy of Sciences 638 167-76.
20. Bernfield, M., Kökényesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L., Lose, E.J. (1992) Biology of the syndecans: a family of four transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology 8, 365-393.
21. Elenius, K., Jalkanen, M. (1994) Function of the syndecans -a family of cell surface proteoglycans. Journal of Cell Science 107, 2975-82.
22. Van Putten, J.P., Paul, S.M. (1995) Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorhoae entry into human mucosal cells. EMBO Journal 14, 2144-54.
23. Fervert, U., Sinnis, P., Cerami, C., Scheffler, W., Takacs, B., Nussenzweig, V. (1993) Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated the surface membrane of hepatocytes. Journal of Experimental Medicine 177, 1287-98.
24. Dhodapkar, M.V., Abe, E., Theus, A., Lacy, M., Langford, J.K., Barlogie, B., Sanderson, R.D. (1998) Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth and bone cell differentiation. Blood, 91, 2679-2688.
25. Lander, A.D. (1998) Proteoglycans: Master regulators of molecular encounter? Matrix Biology 17, 465-472.
26. Steinfield, R., Van Den Berghe, H., David, G. (1996) Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. Journal of Cell Biology 133, 319-323.
27. Engeelmann, S., Ebeling, O., Schwartz-Albiez, R. (1995) Modulated glycolysation of proteoglycans during differentialion of human B lymphocytes. Biochemica Biophysica Acta 1267:6-14.
28. Submarian, S.V., Fitzgerald, M.L., Bernfield, M. (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. Journal of Biological Chemistry, 272, 14713-14720.
29. Ihreke, N.S., Platt, J.L. (1996) Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell surface molecules. Journal of Cellular Physiology 168, 625-637.
30. Reiland, J., Ott, V.L., Lebakken, C.S., Yeaman, C., McCarthy, J., Rapraeger, A.C. (1996) Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. Biochemical Journal 319, 39-47.
31. Wijdenes, J., Clement, C., Klein, B., Dore, J.M. (1997) CD138 cluster report. In: Leukocyte typing VI (edited by Kishimoto et al), New York: Garland.
32. Bernfield, M., Kökényesi, R., Kato, M. Hinkes, M.T., Spring, J., Gallo, R.L., Lose, E.J. al (1992) Biology of the syndecans: a family of four transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology 8, 365-393.
33. Mali, M., Andtfolk, H., Miettinen, H.M., Jalkanen, M. (1994) Suppression of tumor cell growth by syndecan-1 ectodomain. Journal of Biological Chemistry 269, 27795-27798.
34. Carey, D.J., Bendt, K.M., Stahl, R.C. (1996) The cytoplasmic domain of syndecan-1 is required for cytoskeleton association but not detergent insolubility. Identification of essential cytoplasmic domain residues. Journal of Biological Chemistry 271, 15253-15260.
35. Lebakken, C.S., Rapraeger, A.C. (1996) Syndecan-1 mediated cell spreading in transtected human lymphoblastoid (Raji) cells. Journal of the Cell Biology 132, 1209-1221.
36. Carey, D.J., Stahl, R.C., Tucker, B., Bendt, K.A., Cizmeci-Smith, G. (1994) Aggregation-induced association of syndecan-1 with microfilaments mediated by cytoplasmic domain. Experimental Cell Research 214, 12-21.
37. Carey, D.J., Bendt, K.M., Stahl, R.C. (1996) The cytoplasmic domain of syndecan-1 is required ior cytoskeleton association but not detergent insolubility. Journal of Biological Chemistry 271, 15253-15260.
38. Mochly-Rosen, D., Gordon, A.S. (1998) Anchoring proteins for protein kinase C: means for isozyme selectivity. FASEB Journal 12, 35-42.
39. Oh, E.S., Couchman, J.R., Woods, A. (1997) Syndecan-4 proleoglycan regulates the distribution and activity of protein kinase C. Journal of Biological Chemistry 272, 8133-8136.
40. Oh, E.S., Couchman, J.R., Woods, A. (1997) Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. Journal of Biological Chemistry 272, 11805-11811.
41. Oh, E.S., Woods, A., Lim, S.T., Theibert, A.W., Couchman, J.R. (1998) Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-biphosphate. Journal of Biological Chemistry 273, 10624-10629.
42. Lee, D., Oh, E.S., Woods, A., Couchman, J.R., Lee, W. (1998) Solution structure of a syndecan-4 cytoplasmic domain and its interaction with phosphatidylinositol 4.5-biphosphate. J. Biol. Chem. 273, 13022-13029.
43. Baciu, P.C., Goetinck, P.F. (1995) Protein kinase C regulates the recruitment of syndecan-4 into local contact. Molecular Biology of Cell 6, 1503-1513.
44. Kinnunen, T., Kaksonen, M., Saarinen, J., Kalkkinen, N., Peng, H.B., Rauvala, H. (1998) Cortactin/Src-kinase signaling pathway is involved in N-syndecan-dependent neurile out-growth. Journal of Biological Chemistry 273, 10702-10708.
45. Fanning, A.S., Anderson, J.M. (1998) PDZ domains and the formation of protein networks at the plasma membrane. Current Topics of Microbiology 228, 209-233.
46. Grootjans, J.J., Zimmerman, P., Reekmans, G., Smets, A., Degeest, G., Dürr, J., David, G. (1997) Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proceedings of National Academy of Sciences USA 94, 13683-13688.
47. Bredt, D.S. (1998) Sorting out genes that regulate epithelial and neuronal polarity. Cell 94, 691-694.
48. Fuki, I.V., Kuhn, K.M., Lomazov, I.R., Rothman, V.L., Tuszynski, G.P., Iozzo, R.V., Swenson, T.L., Fisher, E.A., Williams, K.J. (1997) The syndecan family of proteoglycans. Journal of Clinical Investigation 100, 1611-1622.
49. Sanderson, R.D., Lalor, P., Bernfield, M. (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regulation 1, 27-35.
50. Carbone, A., Gloghini, A., Gaidano, G., Franceschi, S., Capello, D., Drexler, H.G., Falini, B., Dalla-Favera, R. (1998) Expression status of BCL-6 and Syndecan-1 identifies distinct hislogenetic subtypes of Hodgkin's disease. Blood, 92, 2220-2228.
51. Wrenshall, L.E., Cerra, F.B., Rubinstein, P., Platt, J.L. (1993) Regulation by heparan sulfate and interleukin alpha of ontogenic expression of T cell receptor. CD4, and CD8 in developing thymus. Human Immunology 38, 165-171.
52. Yamashita, Y., Oritani, K., Miyoshi, E.K., Wall, R., Bernfield, M., Kincade, P.W. (1999) Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. Journal of Immunology, 162, 5940-5948.
53. Stocker, G., Drezinek, Z., Just, U., Ostertag, W., Siebertz, B., Grelling, H., Haubeck, H.D. (1996) Proteoglycan synthesis in human and murine haematopoietic progenitor cell lines: isolation and characterisation of a heparan sulafte proteoglycan as major proleoglycan from the human haematopoietic cell line TF-1. Biochemical Journal 317, 203-212.
54. Oritani, K., Kincade, P.W. (1996) Identification of stromal cell products that interact with pre-B cells. Journal of Cellular Biology 134, 771-782.
55. Sneed, T.B., Stanley, D.J., Young, L.A., Sanderson, R.D. (1994) Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells. Cellular Immunology 153, 456-467.
56. Rapraeger, A. (1989) Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. Journal of Cellular Biology 109, 2509-2518.
57. Messika, E.J., Lu, P.S., Sung, Y.J., Yao, T., Chi, J.T., Chien, Y.H., Davis, M.M. (1998) Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. Journal of Experimental Medicine 188: 515-525.
58. Turner, C.A., Mack, D.H., Davis, M.M. (1994) B-limp, a novel Zinc finger containing protein that can drive the maturation of B lymphocytes into imunglobulin-secreting cells. Cell77, 297-306.
59. Usui, T., Wakatsuki, Y., Matsunaga, Y., Kaneko, S., Kosek, H., Kita, T. (1997) Overexpression of B cell specific activator protein (BSAP/Pax-5) in late cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. Journal of Immunology 158, 3097-3204.
60. Stanley, M.J., Liebersbach, B.F., Liu, W., Anhalt, D.J., Sanderson, R.D. (1995) Heparan sulfate mediated cell aggregation. Syndecan-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. Journal of Biological Chemistry 270, 5077-5083.
61. Liebershach, B.F., Sanderson, R.D. (1994) Expression of syndecan-1 inhibits cell invasion into type I collagen. Journal of Biological Chemistry 269: 20013-20019.
62. Liu, W., Litwack, E.D., Stanley, M.J., Langford, J.K., Lander, A.D., Sanderson, R.D. (1998) Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. Journal of Biological Chemistry 273, 22825-22832.
63. Olwin, B.B., Rapraeger, A. (1992) Repression of myogenic differentiation by aFGF, bFGF and K-FGF is dependent on cellular heparan sulfate. Journal of Cellular Biology 118, 631-639.
64. Mitsiadis, T.A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M., Thesleff, I. (1995) Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleitropin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121, 37-51.
65. Filla, M.S., Dam, P., Rapraeger, A.C. (1998) The cell surface proleoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. Journal of Cellular Physiology 174, 310-321.
66. Kopper, L., Sebestyén, A., Gallai, M., Kovalszky, I, (1997) Syndecan-1 - a new piece in B-cell puzzle. Pathology Oncology Research. 3, 183-191.
67. Inki, P., Stenback, F., Talve, L., Jalkanen, M. (1991) Immunhistochemical localization at syndecan in mouse skin tumours induced by UV irradiation. Loss of expression associated with malignant transformation. American Journal of Pathology 139, 1333-1340.
68. Levy, P., Munier, A., Baron-Delage, S., Di Gioia, Y., Gespach, C., Capeau, J., Cherqui, G. (1996) Syndecan-1 alterations during the tumorigenic progression of human colonie Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. British Journal of Cancer 74, 423-431.
69. Dhodapkar, M.V., Sanderson, R.D. (1999) Syndecan-1 (CD138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment. Leukemia Lymphoma, 34, 35-43.
70. Carbone, A., Gaidano, G., Gloghini, A., Larocca, L.M., Capello, D., Canzonieri, V. Antinori, A., Tirelli, U., Falini, B., Dalla-Favera, R. (1998) Differential expression of BCL-6. CD138/Syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndroma-related non-Hodgkin's lymphomas. Blood, 91, 747-755.
71. Carbone, A., Gloghini, A., Gattei, V., Degan, M., Improta, S., Aldinucci, D., Canzonieri, V., Perin, T., Volpe, R., Gaidano, G., Zagonel, V., Pinto, A. (1997) Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood, 89, 3787-3794.
72. Sebestyén, A., Kovalszky, I., Mihalik, R., Gallai, M., Bocsi, J., László, E., Benedek, Sz., Sreter, L, Kopper, L. (1997) Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia. European Journal of Cancer 33, 2273-2277.
73. Gaidano, G., Gloghini, A., Gattei, V., Rossi, M.F., Cilia, A.M., Godeas, C., Degan, M., Perin, T., Canzonieri, V., Aldinucci, D., Saglio, G., Carbone, A., Pinto, A. (1997) Association of Kaposi's Sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/Syndecan-1 antigen. Blood, 90, 4894-4900.
74. Larocca, L.M., Capello, D., Rinelli, A., Nori, S., Antinori, A., Gloghini, A., Cingolani, A., Migliazza, A., Saglio, G., Camilleri-Broet, S., Raphael, M., Carbone, A., Gaidano, G. (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B-cells. Blood, 92, 1011-1019.
75. Gattei, V., Godeas, C., Degan, M., Rossi, F.M., Aldinucci D., Pinto A. (1999) Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells. British Journal of Haematology 104, 152-162.
76. Bonnefoix, T., Sotto, M.-F., Gressin, R., Martin, I., Garban, F., Leroux, D., Renversez, J.-C., Sotto, J.-J. (1998) Phenotypic, morphologic changes and Ig secretion induced on B-NHL cells in vitro by interferon alpha and all-trans-retinoic acid: possible progression toward a more differentiated state. European Journal of Haematology, 61, 84-92.
77. Carbone, A., Gloghini, A., Larocca, L.M., Antinori, A., Falini, B., Tirelli, U., Della-Favera, R., Gaidano, G. (1999) Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. Blood 93, 2319-2326.
78. Carbone, A., Gaidano, G., Gloghini, A., Pastore, C., Saglio, G., Tirelli, U., Dalla-Favera, R., Falini, B. (1997) BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas. Inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. American Journal of Pathology, 150, 155-165.
79. Jourdan, M., Ferlin, M., Legouffe, E., Horvathova, E., Liautatd. J., Rossi, J.F., Wijdenes, J., Brochier, J., Klein, B. (1998) The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Brirtish Journal Haematology, 100, 637-646.
80. Wijdenes, J., Vooijs, W.C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.X., Klein, B., Dore, J.M (1996) A plasmocyte selective monoclonal antibody (B-B4) recognises syndecan-1 British Journal of Haematology 94, 318-323.
81. Ridlley, R.C., Xiao, H., Hata, H., Woodliff, J., Epstein, J., Sanderson, R.D. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen, Blood 81, 767-774.
82. Dhodapkar, M.V., Kelly, T., Theus, A., Athota, A.B., Barlogie, B., Sanderson, R.D. (1997) Elevated levels of shed syndecan-I correlate with tumor mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma. British Journal of Haematology. 99, 368-371.
83. Kaushal, G.P., Xiong, X., Athota, A.B., Rozypal, T.L., Sanderson, R.D., Kelly, T. (1999) Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9. British Journal Haematology, 104, 365-373.
84. Rawstron, A.C., Owen, R.G., Davies, F.E., Johnson, R.J., Jones, R.A., Richards, S.J., Evans, P.A., Child, A., Smith, G.M., Jack, A.S. (1997) Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. British Journal of Heamatology, 97, 46-55.
85. Sanderson, R.D., Turnbull, J.E., Gallagher, J.T., Lander, A.D. (1994) Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. Journal of Biological Chemistry 269: 13100-13106.
86. Rawstron, A., Barrans, S., Blythe, D., Davies, F., English, A., Pratt, G., Child, A., Morgan, G., Jack, A. (1999) Distribution ot myeloma plasma cells in peripheral blood and bone marrow correlated with CD56 expression. British Journal of Haematology 104, 138-143.
87. Witzig, T.E., Kimlinger, T., Stenson, M., Therneau, T. (1998) Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leukemia Lymphoma 31, 167-175.
88. Gattei, V., Godeas, C., Degan, M., Rossi, F.M., Aldinucci, D. (1999) Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells. British Journal Haematology 104, 152-162.